Best Spa Services In Adelaide - 1 views
I really love to pamper myself after a week of hard work. That is why I always visit Shantai Wellness Spa to experience the best Day Spa in Adelaide. I really love their caring, relaxing services i...
Group items tagged
Gorgeous Day Spa Treatment - 1 views
Being a working mom who is also pregnant is not really easy as there are really times when you want to rest but cannot do it because you are at work. It is for this reason that I always find time t...
The dental health Daily - 0 views
-
croydondentist on 20 Jan 17General dentistry involves primary consultations and diagnosis like CAT scans, X-rays and wax moulds to perform replacement of tooth.Learn about the different dental emergency.
Cosmetic Dentistry to Improve Your Smile - Croydon Dentist - 0 views
-
Cosmetic dentistry can improve your smile as well as your allover facial appearance. At Ntureza Dental Practice you can visit best cosmetic dentists in Croydon.
Teeth Whitening Tips to Get a Pearly White Smile - 1 views
Whether teeth have been whitened at the office of dentist or at home, it has been considered the best way to build the confidence by helping someone to smile openly. It is very much important to co...
Otsuka- Lundbeck's schizophrenia drug Abilify Maintena gets Health Canada clearance - 0 views
-
Otsuka and Lundbeck has received approval from Health Canada to use its intramuscular (IM) once-monthly injectable formulation 'Abilify Maintena' for the maintenance treatment of schizophrenia in stabilized adult patients.
BioMarin selects NAGLU fusion protein drug candidate BMN 250 to treat Sanfilippo B synd... - 0 views
-
US-based BioMarin Pharmaceutical has selected a new drug development candidate, BMN 250, for the treatment of Sanfilippo B syndrome or Mucopolysaccharidosis type IIIB (MPS IIIB).
Bristol-Myers Squibb gets FDA breakthrough designation for daclatasvir-based regimen - 0 views
-
PBR Staff Writer Published 25 February 2014 Bristol-Myers Squibb (BMS) has received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for its investigational DCV Dual Regimen (daclatasvir and asunaprevir) for use as a combination therapy in the treatment of genotype 1b chronic hepatitis C infection (HCV).
Pluristem files orphan drug application to US FDA for preeclampsia - 0 views
-
PBR Staff Writer Published 21 February 2014 Israel-based Pluristem Therapeutics has submitted its application to the US Food and Drug Administration seeking Orphan Drug Designation for its PLacental eXpanded (PLX-PAD) cells for the treatment of severe preeclampsia.
Vertex gets FDA approval for Kalydeco sNDA - 0 views
-
PBR Staff Writer Published 24 February 2014 US-based biotechnology firm Vertex Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for a supplemental New Drug Application (sNDA) of its Kalydeco (ivacaftor) for the treatment of people with cystic fibrosis (CF).
TC BioPharm, Medinet to develop new cancer therapies - 1 views
-
Scottish biotechnology firm TC BioPharm (TCB) and Japanese immuno-cell therapy company Medinet have entered into a strategic collaboration to develop a new treatment for different types of cancer.
The Most Reliable Eye Doctors - 1 views
I was so worried of my 10 year old daughter who complained about some eye problems. And because I wanted her to get the best eye treatment, I brought her to Prestonwood EYECARE knowing so well th...
Health and wellness: protein helps your hair grow and lose weight - 0 views
-
protein helps your hair grow and lose weight -Researchers have showed how hair growth activated fat tissue growth within the skin below the follicle may lead to the development of a cream to dissolve fat. particularly, the protein that activated follicle growth was shown to conjointly inhibit fat production
FDA approves GSK's Incruse Ellipta to treat airflow obstruction in COPD patients - 1 views
-
PBR Staff Writer Published 01 May 2014 The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's (GSK) Incruse Ellipta (umeclidinium) for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Umeclidinium is a once-daily long-acting muscarinic antagonist (LAMA), a type of bronchodilator also known as an anticholinergic.
KYTHERA files NDA for ATX-101 to reduce unwanted submental fat - 1 views
-
US-based KYTHERA Biopharmaceuticals has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for ATX-101 (deoxycholic acid) as an injectable treatment for the reduction of submental fat, which commonly presents as a double chin.
Eisai announces launch of Fycompa in Netherlands - 1 views
-
Fycompa (perampanel), the first in an entirely new class of treatment for partial onset seizures (the most common form of epilepsy), will be launched in the Netherlands on 13 May 2014.
Dr.Sloan McCormick, DDS | Dental Practice consultants - 1 views
-
We introduce professional consultants and dentists for the treatment of snoring and sleep apnea.
-
Hello. I have practiced Dental Sleep Medicine exclusively in Fresno, CA for the past 5 years, after a general dentistry practice of 32 years in Santa Cruz, CA. These transition years into sleep dentistry have been the best years yet.
Actavis to settle patent litigation of Daytrana with Noven Pharmaceuticals - 1 views
-
PBR Staff Writer Published 20 March 2014 Ireland-based specialty pharmaceutical firm Actavis has entered into an agreement with Noven Pharmaceuticals to settle all outstanding patent litigation related to its generic version of Daytrana (Methylphenidate Transdermal System). Daytrana is a CNS stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.
Way to Have Drug Free Life - 0 views
-
These days, one of the biggest problems that are faced by the people in the whole world is drug addiction. In fact, it has been seen that most of the people are addicted to prescription drugs rather than illegal drugs...
« First
‹ Previous
501 - 520 of 599
Next ›
Last »
Showing 20▼ items per page